Despite unfavorable contributions from multi-factor stock selection models and underexposures to negative earners in the Russell 1000 Growth Index, The Glenmede Quantitative U.S. Large Cap Growth Equity Strategy produced relatively in-line performance with the Russell 1000 Growth Index. Portfolio Manager Val de Vassal,CFA,  reviews how the strategy benefited from its underexposures to some of the largest mega-cap stocks and relatively lower market capitalizations versus the benchmark. He explains how the diversified strategy remains well-positioned with its multifactor approach favoring stocks with cheaper valuations, stronger fundamentals, positive earnings/revenue estimate trends and attractive technicals.